Cheng-Tang Chiu

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.

A. Gasbarrini, B. Sands, I. Lawrance, 2023, Gastroenterology.

Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer.

Yuan-Ming Yeh, Chyi-Liang Chen, J. Hsieh, 2024, Biomedical journal.